Efficacy of Apixaban in the Treatment of Portal Vein Thrombosis Occurring More Than One Year After LS
NCT07461545
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Cirrhosis
Splenectomy
Portal Vein Thrombosis
Hypertension, Portal
Interventions
DRUG:
Apixaban 2.5 MG
Sponsor
Northern Jiangsu People's Hospital